These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35599952)

  • 1. Bilateral horizontal gaze palsy due to Anti-IgLON5 disease.
    Bhatti MT
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101574. PubMed ID: 35599952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.
    McWilliam O; Gramkow MH; Blaabjerg M; Clemmensen FK; Hasselbalch SG; Frederiksen KS
    J Neurol; 2024 Apr; 271(4):1707-1716. PubMed ID: 38195895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature.
    Grossauer A; Hussl A; Mahlknecht P; Peball M; Heidbreder A; Deisenhammer F; Djamshidian A; Seppi K; Heim B
    Mov Disord Clin Pract; 2023 Jan; 10(1):115-119. PubMed ID: 36698996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder.
    El Shazly J; Juenemann M; Gerriets T; Tschernatsch M
    Front Neurol; 2021; 12():632497. PubMed ID: 33633675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Anti-IgLON5 Disease Showing an Improvement in Dysautonomia, Including Vocal Cord Palsy, via Combined Immunotherapy.
    Sato D; Sato H; Kondo T; Igari R; Iseki C; Kawahara H; Amano S; Ono Y; Kimura A; Shimohata T; Ohta Y
    Intern Med; 2024 Jan; ():. PubMed ID: 38171876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ioflupane single-photon emission computed tomography in anti-IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature.
    González-Ávila C; Casado L; Muro García I; Villacieros-Álvarez J; Vivancos J; Quintas S
    Eur J Neurol; 2021 Apr; 28(4):1392-1395. PubMed ID: 33175431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature.
    Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S
    J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.
    Gaig C; Compta Y
    Curr Opin Neurol; 2019 Jun; 32(3):493-499. PubMed ID: 30694925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical neurological manifestations in anti-IgLON5 disease: a case report.
    Chen Y; Chen J; Pei Z; Qian W
    Front Neurol; 2024; 15():1340284. PubMed ID: 38450066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Motor Abnormalities in Anti-IgLON5 Disease.
    Macher S; Milenkovic I; Zrzavy T; Höftberger R; Seidel S; Berger-Sieczkowski E; Berger T; Rommer PS; Wiest G
    Front Immunol; 2021; 12():753856. PubMed ID: 34659261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
    Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
    Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.
    Li Y; Jia Y
    Front Immunol; 2023; 14():1195341. PubMed ID: 37383232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.
    Gaig C; Compta Y; Heidbreder A; Marti MJ; Titulaer MJ; Crijnen Y; Högl B; Lewerenz J; Erro ME; García-Moncó JC; Nigro P; Tambasco N; Patalong-Ogiewa M; Erdler M; Macher S; Berger-Sieczkowski E; Höftberger R; Geis C; Hutterer M; Milán-Tomás A; Martin-Bastida A; Manzanares LL; Quintas S; Höglinger GU; Möhn N; Schöberl F; Thaler FS; Asioli GM; Provini F; Plazzi G; Berganzo K; Blaabjerg M; Brüggemann N; Farias T; Ng CF; Giordana C; Herrero-San Martín A; Huebra L; Kotschet K; Liendl H; Montojo T; Morata C; Pérez-Pérez J; Puertas I; Seifert-Held T; Seitz C; Simabukuro MM; Téllez N; Villacieros-Álvarez J; Willekens B; Sabater L; Iranzo A; Santamaria J; Dalmau J; Graus F
    Neurology; 2021 Oct; 97(14):e1367-e1381. PubMed ID: 34380749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epileptic Seizures and Right-Sided Hippocampal Swelling as Presenting Symptoms of Anti-IgLON5 Disease: A Case Report and Systematic Review of the Literature.
    Fu Y; Zou X; Liu L
    Front Neurol; 2022; 13():800298. PubMed ID: 35620785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations of the anti-IgLON5 disease.
    Gaig C; Graus F; Compta Y; Högl B; Bataller L; Brüggemann N; Giordana C; Heidbreder A; Kotschet K; Lewerenz J; Macher S; Martí MJ; Montojo T; Pérez-Pérez J; Puertas I; Seitz C; Simabukuro M; Téllez N; Wandinger KP; Iranzo A; Ercilla G; Sabater L; Santamaría J; Dalmau J
    Neurology; 2017 May; 88(18):1736-1743. PubMed ID: 28381508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of IgLON5-IgG and SOX1-IgG in a Patient with Progressive Brainstem Dysfunction.
    Teekaput C; Teekaput K; Tanprawate S; Kittisares A; Apiwattanakul M
    Acta Neurol Taiwan; 2023 Sep; 32(3)():131-135. PubMed ID: 37674426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgLON5 autoimmunity tested positive in patients with isolated chronic insomnia disease.
    Aghelan Z; Karima S; Ghadami MR; Khazaie H; Bahrehmand F; Vaisi-Raygani A; Abtahi SH; Khodarahmi R
    Clin Exp Immunol; 2022 Apr; 207(2):237-240. PubMed ID: 35020856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.
    Nissen MS; Blaabjerg M
    Front Neurol; 2019; 10():1056. PubMed ID: 31632341
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report.
    Wang Y; Wu X; Lu B
    BMC Neurol; 2021 Mar; 21(1):120. PubMed ID: 33731000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes.
    Montagna M; Amir R; De Volder I; Lammens M; Huyskens J; Willekens B
    Front Neurol; 2018; 9():329. PubMed ID: 29867738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.